US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist
  • 54.140
  • -0.570-1.04%
Close Nov 8 16:00 ET
  • 54.140
  • 0.0000.00%
Post 20:01 ET
109.81BMarket Cap-15122P/E (TTM)

Bristol-Myers Squibb Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
8.44%11.89B
8.69%12.2B
4.66%11.87B
-2.50%45.01B
0.62%11.48B
-2.25%10.97B
-5.56%11.23B
-2.67%11.34B
-0.49%46.16B
-4.83%11.41B
Operating revenue
7.47%11.59B
8.52%12.04B
4.48%11.69B
-2.26%44.39B
0.60%11.32B
-1.85%10.78B
-5.03%11.1B
-2.64%11.19B
-0.78%45.41B
-4.93%11.25B
Cost of revenue
18.00%2.96B
13.60%3.27B
14.26%2.93B
5.48%10.69B
5.86%2.75B
6.50%2.51B
5.74%2.88B
3.84%2.57B
1.98%10.14B
10.06%2.59B
Gross profit
5.61%8.94B
6.99%8.93B
1.85%8.93B
-4.74%34.31B
-0.92%8.73B
-4.57%8.46B
-8.91%8.35B
-4.42%8.77B
-1.16%36.02B
-8.47%8.81B
Operating expense
4.03%6.76B
12.31%7.24B
17.04%7.42B
-2.97%26.12B
-4.07%6.83B
-3.92%6.5B
-1.16%6.45B
-2.60%6.34B
-3.55%26.92B
-2.33%7.12B
Selling and administrative expenses
-1.00%1.98B
-0.31%1.93B
34.34%2.37B
-0.54%7.77B
-8.52%2.07B
3.78%2B
8.23%1.93B
-3.77%1.76B
1.61%7.81B
-3.74%2.27B
-Selling and marketing expense
-1.00%1.98B
----
34.34%2.37B
----
----
3.78%2B
----
-3.77%1.76B
----
----
Research and development costs
5.89%2.37B
28.39%2.9B
16.11%2.7B
-2.21%9.3B
-1.27%2.48B
-7.28%2.24B
-2.71%2.26B
2.70%2.32B
-6.73%9.51B
-0.32%2.51B
Depreciation amortization depletion
6.65%2.41B
7.04%2.42B
4.48%2.36B
-5.71%9.05B
-2.77%2.28B
-6.70%2.26B
-6.62%2.26B
-6.66%2.26B
-4.27%9.6B
-3.06%2.34B
-Depreciation and amortization
6.65%2.41B
7.04%2.42B
4.48%2.36B
-5.71%9.05B
-2.77%2.28B
-6.70%2.26B
-6.62%2.26B
-6.66%2.26B
-4.27%9.6B
-3.06%2.34B
Operating profit
10.87%2.17B
-11.05%1.69B
-37.75%1.51B
-9.98%8.2B
12.34%1.9B
-6.67%1.96B
-28.05%1.9B
-8.88%2.43B
6.64%9.1B
-27.61%1.69B
Net non-operating interest income expense
-80.36%-505M
-84.75%-521M
-47.57%-425M
5.36%-1.17B
-7.48%-316M
6.35%-280M
9.90%-282M
11.66%-288M
7.65%-1.23B
8.98%-294M
Non-operating interest expense
80.36%505M
84.75%521M
47.57%425M
-5.36%1.17B
7.48%316M
-6.35%280M
-9.90%282M
-11.66%288M
-7.65%1.23B
-8.98%294M
Other net income (expense)
-98.03%9M
-51.67%116M
-2,113.58%-12.61B
987.42%1.41B
-81.05%87M
11.98%458M
164.69%240M
195.43%626M
-117.77%-159M
388.68%459M
Gain on sale of security
-0.93%106M
424.32%194M
637.74%285M
145.87%289M
-19.84%198M
181.58%107M
113.17%37M
91.64%-53M
-180.36%-630M
--247M
Special income (charges)
-87.65%-456M
-65.94%-536M
-11,557.76%-13.29B
63.99%-260M
-64.22%190M
-18.54%-243M
42.32%-323M
123.77%116M
30.44%-722M
24.36%531M
-Less:Restructuring and merger&acquisition
48.73%409M
41.52%467M
6,258.37%13.29B
14.46%1.51B
350.32%698M
70.81%275M
-39.34%330M
-54.66%209M
-2.15%1.32B
-24.76%155M
-Less:Impairment of capital assets
62.07%47M
----
----
----
----
--29M
----
----
----
----
-Less:Other special charges
----
1,085.71%69M
100.62%2M
-187.84%-390M
-97.95%3M
-238.64%-61M
-143.75%-7M
-236.55%-325M
22.31%444M
342.42%146M
-Gain on sale of business
----
----
----
-17.35%862M
----
----
----
----
54.52%1.04B
24.92%832M
Other non- operating income (expenses)
-39.56%359M
-12.93%458M
-28.77%401M
15.84%1.38B
5.64%-301M
3.13%594M
11.91%526M
20.82%563M
3.83%1.19B
-104.49%-319M
Income before tax
-21.57%1.68B
-30.82%1.29B
-515.74%-11.52B
9.43%8.44B
-9.95%1.67B
-3.26%2.14B
-5.06%1.86B
64.20%2.77B
-4.75%7.71B
0.05%1.86B
Income tax
127.09%461M
-82.57%-398M
-22.07%392M
-70.76%400M
46.99%-88M
-66.22%203M
-141.21%-218M
24.50%503M
26.20%1.37B
67.70%-166M
Net income
-37.18%1.22B
-18.92%1.68B
-625.28%-11.91B
26.71%8.04B
-12.99%1.76B
20.27%1.93B
45.35%2.08B
76.70%2.27B
-9.54%6.35B
-14.63%2.03B
Net income continuous Operations
-37.18%1.22B
-18.92%1.68B
-625.28%-11.91B
26.71%8.04B
-12.99%1.76B
20.27%1.93B
45.35%2.08B
76.70%2.27B
-9.54%6.35B
-14.63%2.03B
Minority interest income
-33.33%4M
0.00%4M
-40.00%3M
-16.67%15M
0
200.00%6M
-50.00%4M
0.00%5M
-10.00%18M
3M
Net income attributable to the parent company
-37.19%1.21B
-18.96%1.68B
-626.57%-11.91B
26.84%8.03B
-12.86%1.76B
20.05%1.93B
45.88%2.07B
77.00%2.26B
-9.54%6.33B
-14.76%2.02B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-37.19%1.21B
-18.96%1.68B
-626.57%-11.91B
26.84%8.03B
-12.86%1.76B
20.05%1.93B
45.88%2.07B
77.00%2.26B
-9.54%6.33B
-14.76%2.02B
Basic earnings per share
-36.17%0.6
-16.16%0.83
-645.37%-5.89
30.64%3.88
-9.38%0.87
25.33%0.94
47.76%0.99
80.00%1.08
-5.71%2.97
-12.86%0.96
Diluted earnings per share
-35.48%0.6
-16.16%0.83
-650.47%-5.89
30.85%3.86
-8.42%0.87
24.00%0.93
50.00%0.99
81.36%1.07
-5.45%2.95
-11.21%0.95
Dividend per share
5.26%0.6
5.26%0.6
5.26%0.6
5.48%2.31
5.26%0.6
5.56%0.57
5.56%0.57
5.56%0.57
8.96%2.19
5.56%0.57
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 8.44%11.89B8.69%12.2B4.66%11.87B-2.50%45.01B0.62%11.48B-2.25%10.97B-5.56%11.23B-2.67%11.34B-0.49%46.16B-4.83%11.41B
Operating revenue 7.47%11.59B8.52%12.04B4.48%11.69B-2.26%44.39B0.60%11.32B-1.85%10.78B-5.03%11.1B-2.64%11.19B-0.78%45.41B-4.93%11.25B
Cost of revenue 18.00%2.96B13.60%3.27B14.26%2.93B5.48%10.69B5.86%2.75B6.50%2.51B5.74%2.88B3.84%2.57B1.98%10.14B10.06%2.59B
Gross profit 5.61%8.94B6.99%8.93B1.85%8.93B-4.74%34.31B-0.92%8.73B-4.57%8.46B-8.91%8.35B-4.42%8.77B-1.16%36.02B-8.47%8.81B
Operating expense 4.03%6.76B12.31%7.24B17.04%7.42B-2.97%26.12B-4.07%6.83B-3.92%6.5B-1.16%6.45B-2.60%6.34B-3.55%26.92B-2.33%7.12B
Selling and administrative expenses -1.00%1.98B-0.31%1.93B34.34%2.37B-0.54%7.77B-8.52%2.07B3.78%2B8.23%1.93B-3.77%1.76B1.61%7.81B-3.74%2.27B
-Selling and marketing expense -1.00%1.98B----34.34%2.37B--------3.78%2B-----3.77%1.76B--------
Research and development costs 5.89%2.37B28.39%2.9B16.11%2.7B-2.21%9.3B-1.27%2.48B-7.28%2.24B-2.71%2.26B2.70%2.32B-6.73%9.51B-0.32%2.51B
Depreciation amortization depletion 6.65%2.41B7.04%2.42B4.48%2.36B-5.71%9.05B-2.77%2.28B-6.70%2.26B-6.62%2.26B-6.66%2.26B-4.27%9.6B-3.06%2.34B
-Depreciation and amortization 6.65%2.41B7.04%2.42B4.48%2.36B-5.71%9.05B-2.77%2.28B-6.70%2.26B-6.62%2.26B-6.66%2.26B-4.27%9.6B-3.06%2.34B
Operating profit 10.87%2.17B-11.05%1.69B-37.75%1.51B-9.98%8.2B12.34%1.9B-6.67%1.96B-28.05%1.9B-8.88%2.43B6.64%9.1B-27.61%1.69B
Net non-operating interest income expense -80.36%-505M-84.75%-521M-47.57%-425M5.36%-1.17B-7.48%-316M6.35%-280M9.90%-282M11.66%-288M7.65%-1.23B8.98%-294M
Non-operating interest expense 80.36%505M84.75%521M47.57%425M-5.36%1.17B7.48%316M-6.35%280M-9.90%282M-11.66%288M-7.65%1.23B-8.98%294M
Other net income (expense) -98.03%9M-51.67%116M-2,113.58%-12.61B987.42%1.41B-81.05%87M11.98%458M164.69%240M195.43%626M-117.77%-159M388.68%459M
Gain on sale of security -0.93%106M424.32%194M637.74%285M145.87%289M-19.84%198M181.58%107M113.17%37M91.64%-53M-180.36%-630M--247M
Special income (charges) -87.65%-456M-65.94%-536M-11,557.76%-13.29B63.99%-260M-64.22%190M-18.54%-243M42.32%-323M123.77%116M30.44%-722M24.36%531M
-Less:Restructuring and merger&acquisition 48.73%409M41.52%467M6,258.37%13.29B14.46%1.51B350.32%698M70.81%275M-39.34%330M-54.66%209M-2.15%1.32B-24.76%155M
-Less:Impairment of capital assets 62.07%47M------------------29M----------------
-Less:Other special charges ----1,085.71%69M100.62%2M-187.84%-390M-97.95%3M-238.64%-61M-143.75%-7M-236.55%-325M22.31%444M342.42%146M
-Gain on sale of business -------------17.35%862M----------------54.52%1.04B24.92%832M
Other non- operating income (expenses) -39.56%359M-12.93%458M-28.77%401M15.84%1.38B5.64%-301M3.13%594M11.91%526M20.82%563M3.83%1.19B-104.49%-319M
Income before tax -21.57%1.68B-30.82%1.29B-515.74%-11.52B9.43%8.44B-9.95%1.67B-3.26%2.14B-5.06%1.86B64.20%2.77B-4.75%7.71B0.05%1.86B
Income tax 127.09%461M-82.57%-398M-22.07%392M-70.76%400M46.99%-88M-66.22%203M-141.21%-218M24.50%503M26.20%1.37B67.70%-166M
Net income -37.18%1.22B-18.92%1.68B-625.28%-11.91B26.71%8.04B-12.99%1.76B20.27%1.93B45.35%2.08B76.70%2.27B-9.54%6.35B-14.63%2.03B
Net income continuous Operations -37.18%1.22B-18.92%1.68B-625.28%-11.91B26.71%8.04B-12.99%1.76B20.27%1.93B45.35%2.08B76.70%2.27B-9.54%6.35B-14.63%2.03B
Minority interest income -33.33%4M0.00%4M-40.00%3M-16.67%15M0200.00%6M-50.00%4M0.00%5M-10.00%18M3M
Net income attributable to the parent company -37.19%1.21B-18.96%1.68B-626.57%-11.91B26.84%8.03B-12.86%1.76B20.05%1.93B45.88%2.07B77.00%2.26B-9.54%6.33B-14.76%2.02B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -37.19%1.21B-18.96%1.68B-626.57%-11.91B26.84%8.03B-12.86%1.76B20.05%1.93B45.88%2.07B77.00%2.26B-9.54%6.33B-14.76%2.02B
Basic earnings per share -36.17%0.6-16.16%0.83-645.37%-5.8930.64%3.88-9.38%0.8725.33%0.9447.76%0.9980.00%1.08-5.71%2.97-12.86%0.96
Diluted earnings per share -35.48%0.6-16.16%0.83-650.47%-5.8930.85%3.86-8.42%0.8724.00%0.9350.00%0.9981.36%1.07-5.45%2.95-11.21%0.95
Dividend per share 5.26%0.65.26%0.65.26%0.65.48%2.315.26%0.65.56%0.575.56%0.575.56%0.578.96%2.195.56%0.57
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data